Pharmaceutical Technology

MAY 22, 2023

The Covid-19 pandemic saw a proliferation in novel vaccine technologies being produced rapidly. With the emergence of vaccines came accusations of technology encroachment amongst biotech companies. 2021 was a year of continued innovation and change in the Biopharmaceutical industry.

Vaccines 116

Vaccines Communication 116

pharmaphorum

MARCH 4, 2021

Germany has decided that AstraZeneca’s COVID-19 vaccine should be approved for use in the over-65s after all, reversing its earlier restriction in that age group. . — Jens Spahn (@jensspahn) March 4, 2021. France has said the vaccine can be used in people aged up to 74, rather than the entire over 65s age group.

Vaccines 64

Vaccines Communication 64

Pharmaceutical Technology

APRIL 25, 2023

As the prophylactic landscape for malaria has changed in recent years with vaccine approvals, major issues still remain with ensuring access in remote communities. However, making sure the vaccine reaches everyone can be challenging due to the storage requirements. The Mosquirix vaccine contains two vials.

Vaccines 69

Vaccines Pharmaceutical Companies Pharmaceutical Companies Communication 69

European Pharmaceutical Review

JUNE 27, 2022

This is in line with the targets set by both the United Nation (UN)’s Sustainable Development Goal 3 on NTDs and the World Health Organization (WHO)’s Neglected Tropical Disease Roadmap (2021-2030). reducing AMR by advancing the vaccine pipeline, including first-in-class vaccines against invasive non-typhoidal salmonellosis and shigellosis .

Vaccines 110

Vaccines Communication Documentation Compounding 110

pharmaphorum

MAY 26, 2021

People can opt out of the scheme by filling in a form and taking it to their GP before 23 June, but campaigners say this has not been communicated effectively. — Foxglove (@Foxglovelegal) May 26, 2021. For news on this case, sign up here: [link].

Communication 116

Communication Pharmaceutical Companies Pharmaceutical Companies Vaccines 116

Digital Pharmacist

AUGUST 8, 2023

In this blog, we will explore what pharmacies should know about the recent surge in COVID-19, the co-occurrence of Flu and RSV, and the significance of vaccinations and testing in controlling these infections. The CDC also states, all existing variants are offshoots of the Omicron strain, which first emerged in late 2021.

Vaccines 93

Vaccines HIPAA Communication Hospitals 93

pharmaphorum

JANUARY 8, 2021

As COVID-19 vaccines are hastily deployed in the UK for priority groups, a debate rages over the government’s controversial strategy to delay time between vaccine doses. When the UK announced the approval of the Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines, it marked an exciting moment for the nation.

Vaccines 59

Vaccines Immunization Medical Schools FDA 59

pharmaphorum

JANUARY 8, 2021

As COVID-19 vaccines are hastily deployed in the UK for priority groups, a debate rages over the government’s controversial strategy to delay time between vaccine doses. When the UK announced the approval of the Pfizer-BioNTech and Oxford/AstraZeneca COVID-19 vaccines, it marked an exciting moment for the nation.

Vaccines 59

Vaccines Immunization Medical Schools FDA 59

Pharmaceutical Technology

MARCH 24, 2023

Since the first human administration of the Bacillus Calmette-Guérin vaccine in 1921, no one has been able to successfully follow the vaccine’s path to become the next approved vaccine to tackle tuberculosis (TB). However, as the TB-related death toll remains high, the global need for another vaccine is steadily rising.

Vaccines 64

Vaccines Health and Personal Care Stores Immunization Communication 64

Pharmaceutical Technology

FEBRUARY 1, 2023

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. This is a significant increase compared to the 2021–20 season when the rate was 28.3 According to the Centers for Disease Control and Prevention (CDC) , 45.8

Vaccines 64

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA 64

Pharmaceutical Technology

MAY 4, 2023

After a winter marked by a rise in hospitalisations due to the RSV, the FDA has granted its first approval for an Respiratory Syncytial Virus (RSV) vaccine to GSK’s Arexvy for adults ages 60 years and above. This vaccine specifically prevents RSV-related lower respiratory tract disease (LRTD).

Vaccines 64

Vaccines FDA Communication Immunization 64

pharmaphorum

MARCH 31, 2021

The ways in which we communicate and consume information are constantly transforming. In 2020, the challenges of the COVID-19 pandemic greatly accelerated the pace of this evolution, with wide-reaching effects on many aspects of medical communications. Q1: What are some ways in which data dissemination has evolved in 2020?

Communication 98

Communication Pharmaceutical Companies Pharmaceutical Companies Vaccines 98

Pharmaceutical Technology

JANUARY 20, 2023

In 2020, Moderna made a net loss of $747 million while its investigational mRNA vaccines were under development. However, during the Covid-19 pandemic, the US-based biotech rose to prominence as it was one of the first companies to develop Covid-19 vaccines with its mRNA technology. In 2021, Moderna had a net income of $12.2

Vaccines 98

Vaccines Communication FDA 98

Pharmaceutical Technology

MAY 1, 2023

After a long period of inactivity in RSV vaccine development , two pharmaceutical companies are now approaching regulatory decisions for their RSV vaccines. Both Pfizer and GSK have major approval decisions regarding the use of their RSV vaccines for older adults this May. What incentivises a country to cover a vaccine?

Vaccines 52

Vaccines Nursing Homes Pharmaceutical Companies Pharmaceutical Companies 52

European Pharmaceutical Review

NOVEMBER 9, 2022

Within recent years this situation has been further exacerbated by the COVID-19 pandemic: both directly, through viral vaccine manufacture; and indirectly, through instability in global supply chains. Those available commercially include adenoviral-based vaccines by AstraZeneca and Johnson & Johnson. 2021 [Cited 16 September 2022].

Vaccines 115

Vaccines Documentation Communication Hospitals 115

Pharmaceutical Technology

APRIL 24, 2023

Since then, the field of nanomedicine has steadily progressed to reach high points such as the successful use of nanotechnology to deliver messenger RNA (mRNA)-based Covid-19 vaccines. In the case of most mRNA vaccines, a lipid nanoparticle-based approach was chosen due to its ability to protect the mRNA in the body and prevent degradation.

Vaccines 59

Vaccines Immunization Medical Schools FDA 59

Digital Pharmacist

NOVEMBER 21, 2022

Food and Drug Administration (FDA) announced its approval of the Boostrix vaccine, commonly known as Tdap (combination of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis) for immunization administration during the third trimester of pregnancy to prevent pertussis in infants younger than two months of age.

Communication 98

Communication Documentation Immunization Vaccines 98

European Pharmaceutical Review

SEPTEMBER 22, 2023

Active anti-Abeta immunotherapies In the 2000s, the concept of active immunotherapy targeting Abeta in Alzheimer’s patients was assessed with the ELAN vaccine (AN1792), consisting of full-length aggregated Abeta 1-42 peptide mixed with the QS21 adjuvant. 8 However, as this trial was not placebo-controlled, conclusions are difficult to draw.

Immunization 97

Immunization Vaccines Communication Labelling 97

Pharmaceutical Technology

DECEMBER 15, 2022

The Singapore Government has launched Biologics Pharma Innovation Programme Singapore (BioPIPS), which aims to increase the country’s manufacturing capacity for biologics, including recombinant proteins and vaccines. 2021 was a year of continued innovation and change in the Biopharmaceutical industry. Additionally, Merck & Co.

Vaccines 105

Vaccines Packaging Pharmaceutical Companies Pharmaceutical Companies 105

Pharmaceutical Technology

MAY 30, 2023

million government grant from the Flanders Innovation & Entrepreneurship (VLAIO) agency that will be used to fuel the company’s vaccine platform, per a 30 May announcement. The company’s prophylactic yellow fever vaccine is part of its plasmid-launched live attenuated virus (PLLAV) platform. AstriVax has received a €2.5

Vaccines 52

Vaccines Communication 52

pharmaphorum

MARCH 15, 2022

Towards the conclusion of 2021 many societies announced another shift in format; 2022 conferences would be hybrid, or increasingly and more realistically described as ‘physical with virtual participation options,’ or similar. This article summarises the most important lessons learnt during 2020 – 2021. Lessons learnt 2020-2021.

Labelling 105

Labelling Vaccines Communication 105

pharmaphorum

NOVEMBER 27, 2022

Supply chain challenges take many forms in pharma – from capacity issues, to managing excess safety stock, and ensuring accurate supplier communication. Better communication with traceable data. Automated systems allow suppliers to maintain complete traceability over their processes and communicate in the most effective way possible.

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 105

pharmaphorum

APRIL 8, 2021

COVID-19 has been a trial-by-fire showing just how quickly drugs and vaccines can be developed under the right circumstances – but there is much to do to ensure this progress is not lost, said speakers at WIRED Health 2021, including the CEOs of BioNTech and BenevolentAI. . BioNTech seeks “new kind of pharma company”.

Vaccines 93

Vaccines Documentation Communication 93

pharmaphorum

APRIL 30, 2021

Not only has COVID forced companies, governments and healthcare systems to work towards approving drugs and vaccines in record times, the sector is also facing an influx of digital therapeutics and advanced drugs that don’t fit neatly into existing access frameworks. How to improve payer engagement with tailored value communication.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Communication Vaccines 98

pharmaphorum

DECEMBER 1, 2022

In 2021, a CISCRIP Perceptions and Insights Study reported more disruption to daily routines compared to previous years, citing length of visits, travel, and diagnostic tests as top burdens. Cloud platforms can open two-way communication channels for patients, doctors, and trial administrators to talk and share data, essentially in real-time.

Communication 111

Communication Hospitals Vaccines 111

pharmaphorum

JANUARY 27, 2023

“We’ve almost got an opportunity to take it to the next level now, because we saw this with the collaboration with the COVID vaccine development and roll-out of the vaccination programme. Having the ability of these groups to be able to communicate directly with patients is tremendous.”

Pharmaceutical Companies 111

Pharmaceutical Companies Pharmaceutical Companies Vaccines Documentation 111

Pharmaceutical Technology

APRIL 12, 2023

In 2021, they accounted for 0.2% The Association of the British Pharmaceutical Industry (ABPI) also states that “the use of animals in medical research has played and continues to play an essential role in the development of new medicines and vaccines”. This was part of an investigation into an international primate smuggling ring.

Vaccines 98

Vaccines FDA Pharmaceutical Companies Pharmaceutical Companies 98

pharmaphorum

FEBRUARY 26, 2021

The company has also faced claims that it did not adequately communicate the risks of its opioid painkillers in its marketing, contributing to the US’ ‘opioid epidemic’, and that its talc products could contain small amounts of asbestos and lead to cancer. Litigation & controversy.

Vaccines 126

Vaccines Labelling Communication 126

European Pharmaceutical Review

DECEMBER 23, 2022

With over 90,000 employees across the globe, Sanofi supplies over 5 billion doses of medicines and vaccines every year, supporting the health needs of millions of patients in more than 170 countries. Simplify systems, applications and processes. To address this, we’re focused on two aspects: mindset and tools.

Vaccines 98

Vaccines Communication 98

pharmaphorum

SEPTEMBER 30, 2021

The biggest issue we saw as restrictions eased was that many people weren’t aware they might still be at high risk even after two vaccinations, which left them unable to make informed decisions. We are also closely watching the development of additional options that may protect people who are immunocompromised beyond the vaccine.

Vaccines 52

Vaccines Communication 52

Pharma Marketing Network

AUGUST 26, 2020

Understanding how to modify communication style is a first step. 1 The first vaccine candidates are progressing towards early to mid-2021 approval. They also need training to translate the skills that made them successful in face-to-face situations to achieve similar levels of success in a remote setting.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Vaccines Compounding 98

Pharma Marketing Network

JANUARY 20, 2021

Regarding OWS’s support for vaccine development, Dr Slaoui noted that 5 of the 6 vaccines selected (from a total of 94 programs) are currently in phase 3 development or approved. The response to this crisis has “transformed the vaccine industry.”.

Vaccines 52

Vaccines Immunization Communication 52

pharmaphorum

FEBRUARY 26, 2021

Emma Sutcliffe from NexGen Healthcare Communications looks at how patient insights can bring the invisible challenges of living with a rare condition into plain view. Big pharma might have dominated COVID headlines with its vaccine drive, but behind the scenes an army of SMEs has allowed the UK to respond swiftly to the pandemic.

Vaccines 59

Vaccines Pharmaceutical Companies Pharmaceutical Companies Communication 59

pharmaphorum

OCTOBER 14, 2021

That’s according to the speakers at a roundtable session, held as part of the Reuters Events: Pharma 2021 conference last week, where representatives from across the life science sector answered questions on the future of European healthcare. Takeaways for pharma from the COVID-19 pandemic.

Vaccines 80

Vaccines Communication Insurance 80

Hospital Pharmacy Europe

JANUARY 19, 2023

In 2016, the country’s first National Strategic Plan in Antimicrobial Resistance 2017–2021 was published. By 2021, reductions of 15.2% suicides per 100,000 people in 2021, the majority (75%) were male and poisoning was the second most common method (after hanging), she continued. In England and Wales, there were 10.7

Community Pharmacies 98

Community Pharmacies Hospitals Communication Medical Schools 98

Pharmaceutical Technology

MARCH 20, 2023

For the pharma supply chain in particular, 2020 and 2021 were boom years in terms of investment. The mRNA technology that enabled the largest and fastest vaccine rollout in history is the tip of the innovation iceberg. GlobalData analysis shows virtual trials increased 50% year on year between 2020 and 2021. Source: GlobalData.

Vaccines 90

Vaccines Communication Hospitals 90

Pharmaceutical Technology

FEBRUARY 3, 2023

With scientists fervently developing mRNA vaccines, nucleic acid therapeutics, and viral vector-based gene therapies, clinicians are set to have a growing number of tools available to treat a wide range of conditions, from infectious diseases to genetic disorders and more. The field of genomic medicine has reached a true turning point.

Communication 97

Communication Packaging Dosage Vaccines 97